Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 16/20 | 0.70 |
| ▸ | ADRB1 | P08588 | 4/20 | 0.53 |
| ▸ | DRD2 | P14416 | 2/20 | 0.53 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.53 |
| ▸ | PGR | P06401 | 1/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.53 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | DRD3 | P35462 | 1/20 | 0.53 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL594466 | 1.00 | ADRB2 (0.70) | ADRB2ADRB1DRD2ADRB3PGR | |
| SCHEMBL15271352 | 0.86 | ADRB2 (0.69) | ADRB2ADRB1DRD2ADRB3PGR | |
| SCHEMBL27657195 | 0.86 | ADRB2 (0.69) | ADRB2ADRB1DRD2ADRB3PGR | |
| SCHEMBL593753 | 0.86 | ADRB2 (0.69) | ADRB2ADRB1DRD2ADRB3PGR | |
| SCHEMBL29866225 | 0.86 | ADRB2 (0.69) | ADRB2ADRB1DRD2ADRB3PGR | |
| SCHEMBL721150 | 0.86 | ADRB2 (0.69) | ADRB2ADRB1DRD2ADRB3PGR | |
| SCHEMBL593754 | 0.86 | ADRB2 (0.69) | ADRB2ADRB1DRD2ADRB3PGR | |
| SCHEMBL11818451 | 0.82 | ADRB2 (0.78) | ADRB2ADRB1DRD2ADRB3PGR | |
| SCHEMBL4684534 | 0.80 | ADRA1A (0.71) | ADRB2ADRB1DRD2ADRB3PGR | |
| SCHEMBL11810215 | 0.75 | ADRB2 (0.73) | ADRB2ADRB1DRD2ADRB3PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9730890-B2 | Bronchodilating beta-agonist compositions and methods | MYLAN PHARMACEUTICALS, INC. (US) | 2017-08-15 | — | — | US | disclosed |
| US-20140113965-A1 | BRONCHODILATING BETA-AGONIST COMPOSITIONS AND METHODS | DEY PHARMA, L.P. (US) | 2014-04-24 | — | — | US | disclosed |
| US-8623922-B2 | Bronchodilating Beta-agonist compositions and methods | DEY PHARMA, L.P. (US) | 2014-01-07 | — | — | US | disclosed |
| US-20120309837-A1 | Bronchodilating Beta-Agonist Compositions and Methods | BANERJEE PARTHA S (US) | 2012-12-06 | — | — | US | disclosed |
| US-8114912-B2 | Bronchodilating β-agonist compositions and methods | MYLAN PHARMACEUTICALS, INC. (US) | 2012-02-14 | — | — | US | disclosed |
| US-20100240761-A1 | BRONCHODILATING BETA-AGONIST COMPOSITIONS AND METHODS | DEY, L.P. (US) | 2010-09-23 | — | — | US | disclosed |
| US-20090143475-A1 | BRONCHODILATING BETA-AGONIST COMPOSITIONS AND METHODS | DEY, L.P. (US) | 2009-06-04 | — | — | US | disclosed |
| US-7541385-B2 | Bronchodilating β-agonist compositions and methods | MYLAN TECHNOLOGIES, INC. | 2009-06-02 | — | — | US | disclosed |
| US-7473710-B2 | Bronchodilating beta-agonist compositions and methods | JPMORGAN CHASE BANK, N.A. (US) | 2009-01-06 | — | — | US | disclosed |
| US-7465756-B2 | Bronchodilating beta-agonist compositions and methods | JPMORGAN CHASE BANK, N.A. (US) | 2008-12-16 | — | — | US | disclosed |
| US-20070166235-A1 | BRONCHODILATING BETA-AGONIST COMPOSITIONS AND METHODS | DEY, L.P. (US) | 2007-07-19 | — | — | US | disclosed |
| US-20070166236-A1 | BRONCHODILATING BETA-AGONIST COMPOSITIONS AND METHODS | DEY, L.P. (US) | 2007-07-19 | — | — | US | disclosed |
| US-20070166240-A1 | BRONCHODILATING BETA-AGONIST COMPOSITIONS AND METHODS | DEY, L.P. (US) | 2007-07-19 | — | — | US | disclosed |
| US-20070160541-A1 | BRONCHODILATING BETA-AGONIST COMPOSITIONS AND METHODS | DEY, L.P. (US) | 2007-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070166236-A1 | BRONCHODILATING BETA-AGONIST COMPOSITIONS AND METHODS | ADRB2, ADRB3, ADRB1 | ADRB2 1/4885ADRB1 3/4885DRD2 459/4885 |
| US-20100240761-A1 | BRONCHODILATING BETA-AGONIST COMPOSITIONS AND METHODS | ADRB2, ADRB3, ADRB1 | ADRB2 1/4885ADRB1 3/4885DRD2 459/4885 |
| US-20140113965-A1 | BRONCHODILATING BETA-AGONIST COMPOSITIONS AND METHODS | ADRB2, ADRB3, ADRB1 | ADRB2 1/4885ADRB1 3/4885DRD2 459/4885 |
| US-20120309837-A1 | Bronchodilating Beta-Agonist Compositions and Methods | ADRB2, ADRB3, ADRB1 | ADRB2 1/4885ADRB1 3/4885DRD2 459/4885 |
| US-20070160541-A1 | BRONCHODILATING BETA-AGONIST COMPOSITIONS AND METHODS | ADRB2, ADRB3, ADRB1 | ADRB2 1/4885ADRB1 3/4885DRD2 459/4885 |
| US-20070166235-A1 | BRONCHODILATING BETA-AGONIST COMPOSITIONS AND METHODS | ADRB2, ADRB3, ADRB1 | ADRB2 1/4885ADRB1 3/4885DRD2 459/4885 |
| US-20090143475-A1 | BRONCHODILATING BETA-AGONIST COMPOSITIONS AND METHODS | ADRB2, ADRB3, ADRB1 | ADRB2 1/4885ADRB1 3/4885DRD2 459/4885 |
| US-20070166240-A1 | BRONCHODILATING BETA-AGONIST COMPOSITIONS AND METHODS | ADRB2, ADRB3, ADRB1 | ADRB2 1/4885ADRB1 3/4885DRD2 459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.